Navigation Links
Hospira Announces Certain Preliminary Third-Quarter 2011 Results
Date:10/18/2011

LAKE FOREST, Ill., Oct. 18, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that its preliminary third-quarter 2011 net sales, adjusted* income from operations and adjusted* earnings per share are lower than anticipated primarily due to certain quality actions taken in response to a U.S. Food and Drug Administration (FDA) 2010 warning letter and subsequent observations related to the company's manufacturing facility in Rocky Mount, North Carolina, and device quality and supply-related issues.

"While recently launched product sales continue to drive top-line growth, we were extremely disappointed in the third quarter by developments related to our quality-improvement initiatives that resulted in a significant slowdown of production and an associated impact on our operating performance," said F. Michael Ball, chief executive officer. "As I indicated at our Investor Day in early September, addressing these issues is Hospira's top priority, and our organization is committed to full resolution. I remain confident that Hospira will emerge from this process a stronger, more competitive global company that is optimally positioned to serve the needs of our customers and patients, and deliver strong value to our shareholders."

Preliminary net sales for the quarter were $977 million, an increase of 2.9 percent compared to $949 million in the third quarter of 2010, with the increase primarily driven by continued strong U.S. net sales of the oncolytic docetaxel. On a constant-currency basis, third-quarter net sales increased slightly compared to the third quarter of 2010.

Preliminary adjusted* income from operations for the third quarter of 2011 was $142 million compared to $189 million in the third quarter of 2010. The decline is primarily due to
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Hospira to Host Conference Call for Third-Quarter 2011 Results
2. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
3. Hospira to Host 2011 Investor Day
4. Hospira to Present at the Morgan Stanley Global Healthcare Conference
5. Hospira Expands Board of Directors
6. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
7. Hospira Reports Second-Quarter 2011 Results
8. Hospira to Host Conference Call for Second-Quarter 2011 Results
9. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
10. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
11. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015 Research and Markets ... "Pharmaceutical Regulatory Affairs in China (Basel, Switzerland - November 26-27, ... seminar will provide a detailed overview of the key areas ... Hong Kong , Macau ... - All important aspects of gaining and ...
(Date:9/2/2015)... YORK , Sept. 2, 2015  Seeger Weiss ... implant bellwether trial will commence October 13, 2015. ... using the 510K fast-track approval program, Zimmer NexGen knee ... program only requires that companies provide evidence that the ... product in order to gain permissions. ...
(Date:9/2/2015)... , Sept. 2, 2015 Research and Markets ... "New EU Pharmacovigilance Legislation (London, UK - November ... The 15 new EU modules concerning Pharmacovigilance are ... is conducted in Europe . The ... modules and their requirements, examine how they overlap and ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... Aug. 1, 2011 Reportlinker.com announces that ... in its catalogue: Insulin- ... This package contains 14 ... European countries: Austria, Belgium, Denmark, Finland, France, ...
... Aug. 1, 2011 Reportlinker.com announces that ... in its catalogue: Vaccines ... http://www.reportlinker.com/p0578257/Vaccines---Eastern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This package contains ... Eastern European countries: Bulgaria, Czech Republic, Estonia, ...
Cached Medicine Technology:Insulin- Western Europe 2Vaccines - Eastern Europe 2
(Date:9/3/2015)... ... 2015 , ... “Love in Tokyo” an independent romantic comedy film by Michael ... and will be released on DVD early next year, by Maverick Entertainment. The ... actress and singer/songwriter, and Jason London, lead from “Dazed and Confused.” , “Love ...
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we ... with the traditional health care model, where the primary care physician dictates and the ... want to become educated about their health issues and empowered to choose their own ...
(Date:9/3/2015)... ... , ... James Earl Jones will be hosting an upcoming VOICES IN AMERICA ... will introduce a segment that discusses why it is important for the workplace to ... fostered in any working environment. , Employers are out billions of dollars year after ...
(Date:9/3/2015)... ... ... Fashion designer Kim (29 years old, Honolulu, HI) designed her own successful ... ABC series “Extreme Weight Loss” Season 5 . Standing just 5’1” and weighing ... the motivation to transform when she designed a drop-dead-gorgeous dress and vowed she would ...
(Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... ... at Johns Hopkins University Bloomberg School of Public Health and an internationally recognized ... House Fellows program for 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate ...
Breaking Medicine News(10 mins):Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2
... , ... the Live Life Again Center, a practice offering weight loss surgery in Dallas , ... social networking sites to connect with individuals who are interested in surgical weight loss treatment ... about his practice with the community. , ...
... ... offering free nationwide confidential consultations for users of Yaz and Yasmin birth control pills who ... cardiac issues or had their Gallbladder removed. Women can call toll free at 1-800-856-6405 or ... evaluation form. , ...
... , EMERYVILLE, Calif., Nov. 25 ... company will host two investor events in December: , ... - 9:00 a.m. CT/10:00 a.m. ET , Principal investigators ... myeloma, as featured at the 51st American Society of Hematology (ASH) ...
... , LONG BEACH, Calif., Nov. 25 Thanksgiving ... the greater Long Beach area thanks to Faith In Action/Volunteer ... (IAH), a division of SCAN Health Plan. For more than ... deliver warm Thanksgiving meals to seniors in need in Long ...
... The Bay Area Air Quality Management District is issuing the season,s first ... Air Alert ... or any other solid fuel, both indoors and outdoors. , "Cold, still ... officer of the Air District. "We,re asking Bay Area residents to respect ...
... statistically significant survival benefit from adjuvant tamoxifen among ... levels of phosphorylation of ER-alpha; at serine-118 (ER-alpha ... November 25 in the Journal of the ... breast carcinomas are resistant to tamoxifen. Preclinical studies ...
Cached Medicine News:Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
Ferris Smith Rongeurs, 12 overall length 300 mm....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... It is designed for rigid ... surgeon greater freedom in positioning ... rigid skeletal fixation is designed ... or sitting positions. Craniotomies can ...
Medicine Products: